¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"3"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
3DFEM three-dimensional finite element method
3DFT three-dimensional Fourier transform
3DQCT three-dimensional computed tomography
3H-DFP tritiated diisopropyl-fluorophosphonate
3H-DHE tritiated dihydroergocryptine
3HT tritiated thymidine
3MS modified mini-mental state examination
3n triploid
3PG 3-phosphoglycerate
3¥â-HSD 3¥â-Hydroxy-Steroid Dehydrogenase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
3 beta-HSDH 3 beta-hydroxysteroid dehydrogenase
3 h h
3 MH 3 methyl-L-histidine
3 MT 3 methoxytyramine
3 V ventricle
3"-UTR 3"-untranslated region
3' NTR 3' non-translated region
3' RACE 3' rapid amplification of cDNA ends
3' UT 3' untranslated
3',5'-T2 3',5'-diiodo-L-thyronine
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
3,3'-dichlorobenzidine <chemical> 3,3'-dichloro-4,4'-diaminodiphenyl. A material used in the manufacture of azo dyes that is toxic to skin and carcinogenic in several species.
Pharmacological action: carcinogens.
Chemical name: (1,1'-Biphenyl)-4,4'-diamine, 3,3'-dichloro-
(12 Dec 1998)
3,4-dihydroxy-5-hexaprenylbenzoate methyltransferase <enzyme> Yeast coq3, the 3,4-dihydroxy-5-hexaprenylbenzoate gene encodes the above enzyme; may be required for the biosynthesis of ubiquinone; amino acid sequence given in first source
Registry number: EC 2.1.1.-
Synonym: dhhb methyltransferase
(26 Jun 1999)
3,4-dihydroxybenzoate decarboxylase <enzyme> Catalyses the conversion of catechol to 3,4-dihydroxybenzoate; an oxygen-sensitive, reversible enzyme; isolated from clostridium hydroxybenzoicum
Registry number: EC 4.1.1.63
(26 Jun 1999)
3,4-dihydroxyphenylacetic acid <chemical> 3,4-dihydroxyphenylacetic acid. A metabolite of l-dopa.
Chemical name: Benzeneacetic acid, 3,4-dihydroxy-
(12 Dec 1998)
3,4-dihydroxyphenylalanine An amino acid derived from the amino acid tyrosine. It is formed as the first intermediate in the production of dopamine, a neurotransmitter.
(09 Oct 1997)
3,4-dihydroxyphenylserine aldolase <enzyme> From human brain; cleaves dops into protocatechualdehyde and glycine; requires pyridoxal phosphate for maximal activity
Registry number: EC 4.1.2.-
Synonym: dops aldolase, l-threo-3,4-dihydroxyphenylserine aldolase
(26 Jun 1999)
3,4-dihydroxyxanthone dioxygenase <enzyme> Forms 4-hydroxy-3-(2'-oxo-3-trans-butenoate)coumarin
Registry number: EC 1.13.11.-
Synonym: 3,4-dhx dioxygenase
(26 Jun 1999)
3,4-methylenedioxyamphetamine <chemical> An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Pharmacological action: adrenergic uptake inhibitors, hallucinogens, serotonin agents.
Chemical name: 1,3-Benzodioxole-5-ethanamine, alpha-methyl-
(12 Dec 1998)
3,4-methylenedioxymethamphetamine A centrally active phenethylamine derivative related to amphetamine and methamphetamine, with central nervous system excitant and hallucinogenic properties.
Synonym: 3,4-methylenedioxymethamphetamine.
(05 Mar 2000)
3,5,3'-triiodothyronine A thyroid hormone normally synthesised in smaller quantities than thyroxine; present in blood and in thyroid gland and exerts the same biological effects as thyroxine but, on a molecular basis, is more potent and the onset of its effect is more rapid.
(05 Mar 2000)
3,5-cyclohexadiene-1,2-diol-1-carboxylate dehydrogenase <enzyme> Catalyses the oxidation of 3,5-cyclohexadiene-1,2-diol-1-carboxylate in presence of nad to yield catechol, carbon dioxide and NADH
Registry number: EC 1.3.1.25
Synonym: dihydrodihydroxybenzoate dehydrogenase
(26 Jun 1999)
3,5-dichlorocatechol 1,2-dioxygenase <enzyme> A nonheme iron dioxygenase involved in biodegradation of the herbicide 2,4-dichlorophenoxyacetic acid; forms 2,4-dichloro-cis,cis-muconic acid
Registry number: EC 1.13.11.-
(26 Jun 1999)
3,5-xylenol methylhydroxylase <enzyme> Requires NADH
Registry number: EC 1.13.-
(26 Jun 1999)
3,6-anhydrogalactose A galactose derivative found in a number of polysaccharides (e.g., agarose).
(05 Mar 2000)
3,6-diaminohexanoate aminomutase <enzyme> Catalyses the isomerization of 3,6-diaminohexanoate to 3,5-diaminohexanoate; minor descriptor (75-83); on-line and index medicus search amino acid isomerases (75-83)
Registry number: EC 5.4.3.3
Synonym: 3,6 diaminohexanoate aminomutase, beta-lysine mutase, beta-lysine aminomutase, beta-lysine 5,6-aminomutase
(26 Jun 1999)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 2
  • 3,3'-Dichlorobenzidine - »õâ A material used in the manufacture of azo dyes that is toxic to skin and carcinogenic in several species.
    Synonyms : 3, 3-Dichlorobenzidine, 3, 3 Dichlorobenzidine, 3, 3' Dichlorobenzidine
  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer - »õâ A non-peptide, kappa-opioid receptor agonist which has also been found to stimulate the release of adrenocorticotropin (ADRENOCORTICOTROPIC HORMONE) via the release of hypothalamic arginine vasopressin (ARGININE VASOPRESSIN) and CORTICOTROPIN-RELEASING HORMONE. (From J Pharmacol Exp Ther 1997;280(1):416-21)
    Synonyms : 3, 4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Mesylate, (trans)-(+)-Isomer, 3, 4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Mesylate, (trans)-(+-)-Isomer, U-50, 488H, U-50488, U-50488H, U50488H, U 50, 488H
  • 3,4-Dihydroxyphenylacetic Acid - »õâ A deaminated metabolite of LEVODOPA.
    Synonyms : 3, 4-Dihydroxyphenylacetic Acid, Monosodium Salt, 3, 4 Dihydroxyphenylacetic Acid
  • 3,4-Methylenedioxyamphetamine - »õâ An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
    Synonyms : 3, 4 Methylenedioxyamphetamine
  • 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) - »õâ A 3-hydroxysteroid dehydrogenase which catalyzes the reversible reduction of the active androgen, DIHYDROTESTOSTERONE to 5 ALPHA-ANDROSTANE-3 ALPHA,17 BETA-DIOL. It also has activity towards other 3-alpha-hydroxysteroids and on 9-, 11- and 15- hydroxyprostaglandins. The enzyme is B-specific in reference to the orientation of reduced NAD or NADPH.
    Synonyms : 3 alpha-Hydroxysteroid Dehydrogenase, 3 alpha-Hydroxysteroid Dehydrogenase (B-Specific), 3 alpha-Hydroxysteroid Oxidoreductase, 3alpha-Hydroxysteroid Dehydrogenase (B-specific), 5 alpha-3 alpha-Hydroxysteroid Dehydrogenase, 5-DP-3 alpha-HSO
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
3β-hydroxysteroid dehydrogenase deficiency an autosomal recessive disorder of steroidogenesis causing several forms of one type of congenital adrenal hyperplasia (type II): the classic forms are salt-wasting and the milder non-salt-wasting, and the nonclassic form is late onset. The enzyme deficiency is present in adrenals and gonads; pathways to cortisol, sex steroids, and aldosterone are blocked; and pregnenolone, 17α-hydroxypregnenolone, and dehydroepiandrosterone are elevated in plasma. Males affected during fetal life are pseudohermaphroditic; both sexes have slight postnatal virilization. Most common is the mildest form (late onset) but of the classic forms, salt-wasting is predominant. See also table at hyperplasia.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
3,3-dichlorobenzidine a gray to purple crystalline solid used in the manufacture of dyes and plastics; it is carcinogenic.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
3,4-benzpyrene benzo[a]pyrene.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
3,4-dihydroxyphenylalanine dopa.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
3,4-dihydroxyphenylglycol a metabolite of norepinephrine; levels may be elevated in pheochromocytoma.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
3 being one more than thirty
3 coming next after the thirtieth in position
3 being two more than thirty
3 the ordinal number of thirty-two in counting order
3 being three more than thirty
3 the ordinal number of thirty-three in counting order
3 being four more than thirty
3 the ordinal number of thirty-four in counting order
3 being five more than thirty
3 the ordinal number of thirty-five in counting order
3 being six more than thirty
3 a year that is not a leap year
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á